[
  {
    "ts": "2025-11-27T15:08:00+00:00",
    "headline": "Familial Hypercholesterolemia Market Intelligence Report 2025-2035 Featuring Regeneron, Amgen, Esperion, Aegerion, Novartis and Other Key Players - Precision Medicine Fuels Personalized Treatment Approaches",
    "summary": "Market growth is propelled by improved diagnosis, genetic screening, and emerging therapies like statins, PCSK9 inhibitors, and gene therapies. Challenges include underdiagnosis and delayed treatment. Key players like Regeneron and Amgen are pioneering innovative solutions, enhancing the market landscape with precision medicine and genetic advancements.Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The \"Familial Hypercholesterolemia Market - A Global and Regional Analysis: Focus on Country and Region",
    "url": "https://finance.yahoo.com/news/familial-hypercholesterolemia-market-intelligence-report-150800516.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "81f12c74-1870-3966-ae38-0ab7e8e8f23d",
      "content": {
        "id": "81f12c74-1870-3966-ae38-0ab7e8e8f23d",
        "contentType": "STORY",
        "title": "Familial Hypercholesterolemia Market Intelligence Report 2025-2035 Featuring Regeneron, Amgen, Esperion, Aegerion, Novartis and Other Key Players - Precision Medicine Fuels Personalized Treatment Approaches",
        "description": "",
        "summary": "Market growth is propelled by improved diagnosis, genetic screening, and emerging therapies like statins, PCSK9 inhibitors, and gene therapies. Challenges include underdiagnosis and delayed treatment. Key players like Regeneron and Amgen are pioneering innovative solutions, enhancing the market landscape with precision medicine and genetic advancements.Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The \"Familial Hypercholesterolemia Market - A Global and Regional Analysis: Focus on Country and Region",
        "pubDate": "2025-11-27T15:08:00Z",
        "displayTime": "2025-11-27T15:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/familial-hypercholesterolemia-market-intelligence-report-150800516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/familial-hypercholesterolemia-market-intelligence-report-150800516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T13:15:00+00:00",
    "headline": "BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential?",
    "summary": "Beam's broad early-stage pipeline and recent study progress take center stage as investors weigh its potential against rival NTLA's prospects.",
    "url": "https://finance.yahoo.com/news/beam-vs-ntla-gene-editing-131500888.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f63fe7c9-eaa7-3423-a471-37d0aaccaf4d",
      "content": {
        "id": "f63fe7c9-eaa7-3423-a471-37d0aaccaf4d",
        "contentType": "STORY",
        "title": "BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential?",
        "description": "",
        "summary": "Beam's broad early-stage pipeline and recent study progress take center stage as investors weigh its potential against rival NTLA's prospects.",
        "pubDate": "2025-11-27T13:15:00Z",
        "displayTime": "2025-11-27T13:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/beam-vs-ntla-gene-editing-131500888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beam-vs-ntla-gene-editing-131500888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": null,
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-27T16:30:12+00:00",
    "headline": "Regeneron (REGN) Up 20.2% Since Last Earnings Report: Can It Continue?",
    "summary": "Regeneron (REGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finance.yahoo.com/news/regeneron-regn-20-2-since-163012558.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "0ac2eed6-556d-3f76-baef-2dcb624fb456",
      "content": {
        "id": "0ac2eed6-556d-3f76-baef-2dcb624fb456",
        "contentType": "STORY",
        "title": "Regeneron (REGN) Up 20.2% Since Last Earnings Report: Can It Continue?",
        "description": "",
        "summary": "Regeneron (REGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
        "pubDate": "2025-11-27T16:30:12Z",
        "displayTime": "2025-11-27T16:30:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
          "originalWidth": 1000,
          "originalHeight": 603,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YgRrCYuBdR1wa08RtjoPHQ--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 1000,
              "height": 603,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jAWLk_UfDMDSToA2irhEEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-regn-20-2-since-163012558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-regn-20-2-since-163012558.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]